In This Section      
Print This Page

Register for the NCCN Policy Summit: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies

Friday, April 25
8:00 AM - 3: 30 PM

Bethesda Marriott
5151 Pooks Hill Road
Bethesda, MD

WHAT:  With cancers increasingly recognized as being comprised of many subtypes differentiated by specific molecular profiles, identifying the most effective combination therapies is challenging. Defining appropriate patient subsets, selecting agents active against specific targets, predicting effective therapeutic combinations and appropriately interpreting clinical trials results are significant problems for pharmaceutical companies, clinicians, statisticians and regulators which will need to be addressed in order to meet the needs of cancer patients.


8:00 – 9:00 AM -  Breakfast and Registration
9:05 – 9:20 AM - Summit Welcome
9:25 – 10:20 AM - Presentation of Conclusions and Recommendations of the Work Group
10:25 – 10:40 AM - Break
10:45 AM – 12:15 PM - Panel Discussion - Strategies for Implementation of Clinical Trials in the Era of Small Subsets and Multiple Agents
12:20 – 1:20 PM - Lunch
1:25 – 2:55 PM - Panel Discussion - Identifying and Defining Standards of Care for Cancer Subtypes
3:00 – 3:30 PM - Wrap up, Conclusions, and Next Steps

Government: $199
Health Care Professional (Other): $299
Industry: $599
Non-Profit/Academia: $299
Patient: $199
Physician: $299


For additional information, contact Elizabeth Danielson at